Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Gavocabtagene autoleucel
Trade Name
Synonyms Gavo-cel|TC 210|TC-210|TC210
Drug Descriptions

Gavocabtagene autoleucel are T cells engineered to express an anti-mesothelin (MSLN) antibody linked to a CD3 epsilon subunit, with potential activity against MSLN-expressing tumors (Cancer Res 2021;81(13_Suppl):Abstract nr CT105).

DrugClasses MSLN Antibody 7
CAS Registry Number NA
NCIT ID C160780


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Gavocabtagene autoleucel Gavocabtagene autoleucel 0 1
Gavocabtagene autoleucel + Ipilimumab + Nivolumab Gavocabtagene autoleucel Ipilimumab Nivolumab 0 1
Gavocabtagene autoleucel + Nivolumab Gavocabtagene autoleucel Nivolumab 0 1

Additional content available in CKB BOOST